Five-year survival for these pediatric aggressive tumors is poor ( 15-35 % ) indicating the need to develop better treatments for pediatric high-grade gliomas .
O O O O O O B-DiseaseOrPhenotypicFeature O O O O O O O O O O O O O O O O B-DiseaseOrPhenotypicFeature O